Middle East & Africa Blood Collection Devices Market

The Middle East & Africa blood collection devices market is expected to grow from US$ 266.85 million in 2022 to US$ 409.00 million by 2030. It is estimated to grow at a CAGR of 5.5% from 2022 to 2030.   

Technological Developments in Blood Collection Techniques and Products Fuel Middle East & Africa Blood Collection Devices Market

Collecting blood from patients with difficult venous access (DVA) is challenging. In the case of DVA patients, the traditionally used blood collection device is often unable to collect adequate samples; this might lead to repeated attempts to collect blood. The risk of anemia can arise due to these repeated attempts and the risk of transmission of blood-borne pathogens to nurses. To avoid such scenarios, market players have launched innovative hematology-tube designs that support capillary blood collection while reducing the risks of blood collection and treatment errors in DVA patients. The new technology offers a painless, needle-free, easy-to-use technique for collecting blood samples. The system allows blood samples to be taken in a nominally invasive manner. Once placed on a patient’s upper arm, hematology-tube improves capillary blood flow beneath the skin through micro-incision and patented skin vasodilation technology.

Middle East & Africa Blood Collection Devices Market Overview

Israel, Iran, Iraq, Kuwait, Oman, Egypt, and Kenya are among the major countries in the Rest of the Middle East & Africa. Growing healthcare spending for better healthcare services is a major factor contributing to the blood collection devices market growth in the Rest of the Middle East & Africa. According to the World Bank Group, the healthcare expenditure of Kuwait and Israel is 6.31% and 8.32% of their GDP, respectively. These countries have been focusing on developing their medical device industry. Further, rising cancer cases in countries such as Israel, Egypt, and Lebanon propel the demand for blood transfusion. According to several publications, ~30,000 cancer cases and ~11,000 cancer-related deaths are recorded in Israel yearly. The Times of Israel reported the geriatric population (aged 75+) would increase by 48% in the country by 2030, creating an urgent need to bolster the health system. Therefore, increasing cancer prevalence and the rising elderly population fuel the demand for enhanced blood testing and blood transfusion therapy in the Rest of the Middle East & Africa, thereby propelling the blood collection devices market growth.

Middle East & Africa Blood Collection Devices Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Blood Collection Devices Strategic Insights

Strategic insights for the Middle East & Africa Blood Collection Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Blood Collection Devices Report Scope

Middle East & Africa Blood Collection Devices Regional Insights

The geographic scope of the Middle East & Africa Blood Collection Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Blood Collection Devices Market Segmentation

The Middle East & Africa blood collection devices market is segmented into product type, methods, end user, and country.

Based on product type, the Middle East & Africa blood collection devices Market is segmented into blood collection tubes, blood collection needles/holders, blood collection set, and others. The blood collection tubes segment held the largest share of the Middle East & Africa blood collection devices market in 2022.

In terms of methods, the Middle East & Africa blood collection devices Market is bifurcated into manual blood collection and automated blood collection. The manual blood collection segment held a larger share of the Middle East & Africa blood collection devices market in 2022.

By end user, the Middle East & Africa blood collection devices market is segmented into hospitals and pathology laboratories, blood bank, and others. The hospitals and pathology laboratories segment held the largest share of the Middle East & Africa blood collection devices market in 2022.

Based on country, the Middle East & Africa blood collection devices market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated Middle East & Africa blood collection devices market in 2022.   

Becton Dickenson and Co, Terumo Corp, Cardinal Health, SARSTEDT AG & Co. KG, NIPRO, Thermo Fisher Scientific Inc, Sekisui Chemical Co Ltd, and Greiner Bio One International GmBH are some of the leading companies operating in the Middle East & Africa blood collection devices market.